NOVN.CH

117.2

+0.15%↑

NOVN.CH

117.2

+0.15%↑

NOVN.CH

117.2

+0.15%↑

NOVN.CH

117.2

+0.15%↑

NOVN.CH

117.2

+0.15%↑

Home・Listă Acțiuni・Roche Holding AG

Roche Holding AG

Închisă

SectorSănătate

327.8 -0.79

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

326.8

Maxim

330.6

Indicatori cheie
By Trading Economics
Venit	1.8B 5.5B
Vânzări	15B 31B
P/E Medie Sector	20.312 51.415
Randament dividend	3
Marjă de profit	17.892
Angajați	103,249
EBITDA	5.1B 12B

Dividende
By Dow Jones
Randament dividend Medie Sector	3.00% 2.34%

Statistici piață
By TradingEconomics
Capitalizare de piață	-30B 259B
Deschiderea anterioară	328.59
Închiderea anterioară	327.8

Sentimentul știrilor

By Acuity

100%

320 / 345 Clasament în Healthcare

Roche Holding AG Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

7 mai 2026, 06:06 UTC

Achiziții, Fuziuni, Preluări

Roche to Buy PathAI for Up to $1.05 Billion to Bolster AI Diagnostics Tools

23 apr. 2026, 07:46 UTC

Câștiguri

Roche Backs Full-Year View as Quarterly Sales Rise -- Update

23 apr. 2026, 05:40 UTC

Câștiguri

Roche Backs Full-Year View as Quarterly Sales Rise

9 mar. 2026, 16:43 UTC

Principalele dinamici ale pieței

Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study -- Update

9 mar. 2026, 15:44 UTC

Principalele dinamici ale pieței

Correction to Roche Shares Article

9 mar. 2026, 09:51 UTC

Principalele dinamici ale pieței

Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study

6 mar. 2026, 09:24 UTC

Principalele dinamici ale pieței

Zealand Pharma Shares Plunge After Obesity Drug Candidate Disappoints in Trial

13 mai 2026, 10:20 UTC

Market Talk

Câștiguri

Roche Strikes Upbeat Tone on Long-Term Outlook -- Market Talk

7 mai 2026, 05:53 UTC

Achiziții, Fuziuni, Preluări

Correct: Roche to Buy PathAI for up to $1.05B

7 mai 2026, 05:07 UTC

Achiziții, Fuziuni, Preluări

Roche: Acquisition Expected to Complete in 2H

7 mai 2026, 05:06 UTC

Achiziții, Fuziuni, Preluări

Roche: Closing of Deal Subject to Customary Closing Conditions

7 mai 2026, 05:06 UTC

Achiziții, Fuziuni, Preluări

Roche to Pay $750M Upfront, Milestone Payments of Up to $300M

7 mai 2026, 05:06 UTC

Achiziții, Fuziuni, Preluări

Roche to Buy PathAI for up to $1.5B

7 mai 2026, 05:05 UTC

Achiziții, Fuziuni, Preluări

Roche to Buy PathAI

6 mai 2026, 22:50 UTC

Câștiguri

Sarepta Stock Sinks on Earnings Beat. Elevidys Demand Faces a Reality Check. -- Barrons.com

27 apr. 2026, 09:54 UTC

Market Talk

Roche's Vabysmo U.S. Recovery Will Be Key -- Market Talk

23 apr. 2026, 08:10 UTC

Market Talk

Câștiguri

Roche Reports In Line Sales Figures -- Market Talk

23 apr. 2026, 05:04 UTC

Câștiguri

Roche Backs 2026 View

23 apr. 2026, 05:04 UTC

Câștiguri

Roche Diagnostics Division 1Q Sales Up at 3% Constant Currency

23 apr. 2026, 05:03 UTC

Câștiguri

Roche Pharmaceutical Division 1Q Sales Up 7% at Constant Currency

23 apr. 2026, 05:02 UTC

Câștiguri

Roche 1Q Group Sales Up 6% at Constant Currency

23 apr. 2026, 05:02 UTC

Câștiguri

Analysts Saw Roche 1Q Sales at CHF14.73B

23 apr. 2026, 05:01 UTC

Câștiguri

Roche 1Q Sales CHF14.72B

10 apr. 2026, 11:28 UTC

Market Talk

Roche's Longer-Term Outlook to Take Spotlight at Diagnostics Event -- Market Talk

10 apr. 2026, 11:17 UTC

Market Talk

Roche to Face Significant Currency Headwinds -- Market Talk

11 mar. 2026, 10:57 UTC

Market Talk

Roche Sees Mixed Fortunes in Immunology, Oncology -- Market Talk

9 mar. 2026, 09:43 UTC

Acțiuni populare

Stocks to Watch Monday: Lamb Weston, Carnival, Pfizer -- WSJ

6 mar. 2026, 07:22 UTC

Market Talk

Roche, Zealand Pharma Obesity Drug Falls Short of Expectations -- Market Talk

3 mar. 2026, 07:22 UTC

Market Talk

Roche's Multiple Sclerosis Drug Safety Remains in Focus After Latest Trial -- Market Talk

2 mar. 2026, 14:21 UTC

Market Talk

Roche's Multiple Sclerosis Drug Might Not Clear FDA Bar -- Market Talk

Comparație

Modificare preț

Roche Holding AG Așteptări

Consens privind evaluarea

By TipRanks

0 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 0 analiști care au acordat evaluări ale acțiunilor Roche Holding AG - Dist în ultimele 3 luni.

Sentiment

By Acuity

320 / 345 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

Alte acțiuni din sector

NOVN.CH

Novartis AG

117.2

↑ +0.15%

Roche Holding AG

Rezumat

Modificarea prețului

Indicatori cheie

Dividende

Statistici piață

Sentimentul știrilor

Roche Holding AG Grafic

Știri relevante

Comparație

Roche Holding AG Așteptări

Consens privind evaluarea

Sentiment

Date financiare

Despre Roche Holding AG

Alte acțiuni din sector